BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit [Seeking Alpha]
BriaCell Therapeutics Corp. - Common Shares (BCTX)
Company Research
Source: Seeking Alpha
Each unit is being sold to the public at a price of $5.59 per unit for gross proceeds of ~$30M. The offering is expected to close on January 15, 2026. The company intends to use the net proceeds to fund working capital requirements, general corporate purposes and the advancement of the company's business objectives. The stock price dropped 9.7% on Tuesday during after-market hours of trading. More on BriaCell Therapeutics Corp. Seeking Alpha's Quant Rating on BriaCell Therapeutics Corp. Financial information for BriaCell Therapeutics Corp. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
BCTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCTX alerts
High impacting BriaCell Therapeutics Corp. - Common Shares news events
Weekly update
A roundup of the hottest topics
BCTX
News
- BriaCell Therapeutics Announces Closing of US$30 million Public OfferingGlobeNewswire
- BriaCell Therapeutics Announces Pricing of $30 million Public OfferingGlobeNewswire
- How $594B in Precision Tech is Cracking the Metastatic Cancer CodePR Newswire
- “Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine [Yahoo! Finance]Yahoo! Finance
- “Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature MedicineGlobeNewswire
BCTX
Sec Filings
- 1/15/26 - Form 8-K
- 1/14/26 - Form 424B4
- 1/14/26 - Form EFFECT
- BCTX's page on the SEC website